ENVALITH
株式会社ユーグレナ logo

Euglena Co.,Ltd.

2931Prime MarketFoods

株式会社ユーグレナ logo
Euglena Co.,Ltd.2931
Reference Indicators

Market Cap

478¥100M

P/E (Forecast)

P/B

1.5x

Dividend Yield (Forecast)

0.00%

ROE

-2.7%

EV/EBITDA

7.6x
Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
34,42044,39246,48247,61850,370
Cost of Sales
12,95113,39614,70714,35015,336
Gross Profit
21,46930,99631,77433,26735,033
SG&A Expenses
28,03434,45233,23932,96631,910
Operating Income
-6,565-3,455-1,4643003,123
Non-operating Income
6941,677680736338
Non-operating Expenses
4837116356051,096
Ordinary Income
-6,354-2,489-1,4194312,365
Extraordinary Income
186487354883
Extraordinary Losses
5694057271,225479
Pre-tax Income
-6,737-2,407-2,110-3051,889
Income Taxes
-900272546-711,363
Net Income
-5,038-2,672-2,652-650-805
EBITDA
-4,373-2801,5063,8986,470
Gross Margin
62.4%69.8%68.4%69.9%69.6%
Operating Margin
-19.1%-7.8%-3.1%0.6%6.2%
ROA
-8.3%-4.7%-4.4%-0.9%-1.1%
ROE
-25.0%-14.1%-13.2%-2.1%-2.7%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
ヘルスケア事業47,0185,48711.7%
バイオ燃料事業1,092-325-29.8%
その他事業2,259-533-23.6%